Mumbai, March 25 -- Concord Biotech has successfully commissioned and commenced
production of injectable at its new manufacturing facility (Unit 4) situated at Valthera.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.